| Q36252752 | "I Cannot Be Worried": Living with Chagas Disease in Tropical Bolivia. |
| Q49584667 | "It's Like a Phantom Disease": Patient Perspectives on Access to Treatment for Chagas Disease in the United States |
| Q35914219 | A Critical Assessment of Officially Reported Chagas Disease Surveillance Data in Mexico |
| Q90469026 | A four-step process for building sustainable access to diagnosis and treatment of Chagas disease |
| Q35836581 | Access to care for Chagas disease in the United States: a health systems analysis |
| Q35636903 | Atlas of Mexican Triatominae (Reduviidae: Hemiptera) and vector transmission of Chagas disease |
| Q55134508 | Barriers to Diagnosis Access for Chagas Disease in Colombia. |
| Q46035700 | Biosensors to Diagnose Chagas Disease: A Brief Review. |
| Q36062986 | Chagas Disease Has Not Been Controlled in Ecuador |
| Q24594371 | Chagas disease in the 21st century: a public health success or an emerging threat? |
| Q37541623 | Chagas disease research and development: Is there light at the end of the tunnel? |
| Q39295410 | Community resilience and Chagas disease in a rural region of Mexico |
| Q55341381 | Complementary Paths to Chagas Disease Elimination: The Impact of Combining Vector Control With Etiological Treatment. |
| Q50054005 | Congenital Transmission of Trypanosoma cruzi in Argentina, Honduras, and Mexico: An Observational Prospective Study. |
| Q35965823 | Cost-Effectiveness of Blood Donation Screening for Trypanosoma cruzi in Mexico. |
| Q92143047 | Economic value of a therapeutic Chagas vaccine for indeterminate and Chagasic cardiomyopathy patients |
| Q64064829 | Estimating the current burden of Chagas disease in Mexico: A systematic review and meta-analysis of epidemiological surveys from 2006 to 2017 |
| Q35345427 | From health advice to taboo: community perspectives on the treatment of sleeping sickness in the Democratic Republic of Congo, a qualitative study |
| Q36069974 | Highly discordant serology against Trypanosoma cruzi in central Veracruz, Mexico: role of the antigen used for diagnostic |
| Q46309809 | Impact of climate change on vector transmission of Trypanosoma cruzi (Chagas, 1909) in North America. |
| Q36278397 | Improving access to Chagas disease diagnosis and etiologic treatment in remote rural communities of the Argentine Chaco through strengthened primary health care and broad social participation |
| Q92434220 | Increasing access to comprehensive care for Chagas disease: development of a patient-centered model in Colombia |
| Q56865867 | Lessons from 20 Years of Capacity Building for Health Systems Thinking |
| Q34181705 | Mother-to-Child Transmission of Trypanosoma cruzi |
| Q49679520 | Neglected tropical diseases in the time of Dr Tedros |
| Q35151454 | Opportunity cost for early treatment of Chagas disease in Mexico |
| Q54228728 | Physician Knowledge, Attitudes, and Practices Related to Chagas Disease in Tabasco, Mexico. |
| Q90305585 | Proposed multidimensional framework for understanding Chagas disease healthcare barriers in the United States |
| Q34640131 | Short report: Increasing access to treatment for Chagas disease: the case of Morelos, Mexico |
| Q51740777 | Socioeconomic benefit to individuals of achieving 2020 targets for four neglected tropical diseases controlled/eliminated by innovative and intensified disease management: Human African trypanosomiasis, leprosy, visceral leishmaniasis, Chagas diseas |
| Q38898612 | Status of vaccine research and development of vaccines for Chagas disease |
| Q48364812 | Ten failings in global neglected tropical diseases control |
| Q33584473 | Ten years of Chagas disease research: Looking back to achievements, looking ahead to challenges |
| Q58611956 | The economic value of identifying and treating Chagas disease patients earlier and the impact on Trypanosoma cruzi transmission |
| Q47551853 | The rise of neglected tropical diseases in the "new Texas". |
| Q48149936 | Trypanosoma cruzi vaccine candidate antigens Tc24 and TSA-1 recall memory immune response associated with HLA-A and -B supertypes in Chagasic chronic patients from Mexico |
| Q96137447 | WHF IASC Roadmap on Chagas Disease |
| Q53239139 | [Strategy to improve access to etiological treatment of Chagas disease at the first level of care in Argentina]. |